Ronald Meeusen

A founding partner of Cultivian Ventures, Mr. Meeusen has more than three decades of experience bringing new technologies and products to market for a number of major corporations. His background includes R&D in agricultural chemicals; field crop and vegetable genetics and breeding; novel foods; and animal health.

In 1986 he planned and conducted the world’s first field trial of a genetically engineered crop trait, and consulted extensively with the government during formation of federal policy on biotechnology regulation. Before that, Dr. Meeusen founded ImmuneWorks, a biopharma company whose board he chairs, and drafted the development strategy for Indiana’s food and ag economy. Prior to that, he led the expansion of Dow AgroSciences’ biotechnology research and development program.